The appropriateness of indication, dose and frequency of antidiabetic drugs adjusted for estimated glomerular filtration rate (eGFR) was evaluated based on recommendations from current guidelines of the Vietnamese Association of Diabetes and Endocrinology 2018, American Diabetes Association 2019 and summary of product characteristics (SPC).